The quick deployment of additional hubs together with an investment in its e-commerce platform enabled it to meet the increased demand as best as possible. “Covid-19 has matured the e-commerce environment and consumer adaptation by three to five years,” the group said. It reported revenue growth of 8.8 % to $690 million compared with last year. Chief executive Ivan Saltzman said in the four and half months, Dis-Chem played a vital role as one of the country’s essential service operators, supplying customers with the necessary medicines and other products during the nationwide lockdown. “Despite the negative factors that constrained regular trading, we remained committed to meeting the needs and demands of our customers. We continue to benefit from the resilient nature of the industry in which we operate and are encouraged by elements of the changing health-care landscape that highlight the importance of our core dispensary and clinic offerings,” Saltzman said. The group saw its retail revenue increase by 6.3 % to $616 million compared with last year while comparable sales growth was 1.5 %. Dis-Chem said it experienced a change in its sales and gross margin mix due to sales restrictions during level 5 of lockdown, with the sales of lower margin Covid-19 related products increasing and reduced impulse purchases because of lower foot traffic. “Covid-19 related products represented approximately 9 % of total retail sales and 13.8 % of front shop sales. --IOL--